4D Molecular Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Emeryville, CA
SEC filing record 1 source field available
Fiscal year end
31 December
4D Molecular Therapeutics, Inc. has filed 421 SEC EDGAR filings since 13 Aug 2015

SEC filing history

Showing 326-350 of 421 matching filings.

Per page
25
Current page
14
4

FORM 4

Filing date
03 Feb 2022
Reporting date
01 Feb 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91921

SC 13G filing

Filing date
04 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-260508

424B4

Filing date
01 Nov 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-260508

EFFECT filing

Filing date
28 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
26 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-260508

S-1

Filing date
26 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
22 Oct 2021
Reporting date
20 Oct 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
13 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS File 377-05573

DRS filing

Filing date
08 Oct 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
01 Oct 2021
Reporting date
29 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
29 Sep 2021
Reporting date
27 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91921

THE SCHEDULE 13G

Filing date
06 Jul 2021
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Jun 2021
Reporting date
07 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
09 Jun 2021
Reporting date
07 Jun 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .